These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11489357)

  • 1. Both hypomethylation and hypermethylation of DNA associated with arsenite exposure in cultures of human cells identified by methylation-sensitive arbitrarily-primed PCR.
    Zhong CX; Mass MJ
    Toxicol Lett; 2001 Jul; 122(3):223-34. PubMed ID: 11489357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion.
    Kuzmin I; Geil L; Ge H; Bengtsson U; Duh FM; Stanbridge EJ; Lerman MI
    Oncogene; 1999 Oct; 18(41):5672-9. PubMed ID: 10523847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
    Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
    Herman JG; Graff JR; Myöhänen S; Nelkin BD; Baylin SB
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9821-6. PubMed ID: 8790415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene.
    Schroeder M; Mass MJ
    Biochem Biophys Res Commun; 1997 Jun; 235(2):403-6. PubMed ID: 9199206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
    Tryndyak V; Kovalchuk O; Pogribny IP
    Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CpG islands hypermethylated in human lung cancer by the arbitrarily primed-PCR method.
    Kohno T; Kawanishi M; Inazawa J; Yokota J
    Hum Genet; 1998 Mar; 102(3):258-64. PubMed ID: 9544836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter.
    Zatyka M; Morrissey C; Kuzmin I; Lerman MI; Latif F; Richards FM; Maher ER
    J Med Genet; 2002 Jul; 39(7):463-72. PubMed ID: 12114475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H
    J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The von Hippel-Lindau (VHL) tumor-suppressor gene is down-regulated by selenium deficiency in Caco-2 cells and rat colon mucosa.
    Uthus E; Begaye A; Ross S; Zeng H
    Biol Trace Elem Res; 2011 Aug; 142(2):223-31. PubMed ID: 20632125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine.
    Alleman WG; Tabios RL; Chandramouli GV; Aprelikova ON; Torres-Cabala C; Mendoza A; Rogers C; Sopko NA; Linehan WM; Vasselli JR
    Clin Cancer Res; 2004 Oct; 10(20):7011-21. PubMed ID: 15501981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
    Zbar B
    Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system.
    Gläsker S; Bender BU; Apel TW; van Velthoven V; Mulligan LM; Zentner J; Neumann HP
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):644-8. PubMed ID: 11309459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
    Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
    Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.